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Pseudomonas aeruginosa is an important pathogen commonly isolated from patients with burns,
wounds and cystic fibrosis (Lyczak et al., 2000; Gellatly and Hancock, 2013). The P. aeruginosa
strain PAO1 was originally reported as a wound isolate from a patient in Australia in 1955
(Holloway, 1955), and has since been studied in many laboratories as a reference strain (Stover
et al., 2000). However, a number of genetic variants of PAO1 in different laboratories have
been reported including a large 2.2 Mb inversion and a number of single nucleotide variants
and insertion-deletion mutations (Stover et al., 2000; Heurlier et al., 2005; Klockgether et al.,
2010).
The type 6 secretion system (T6SS) functions as a molecular weapon that delivers toxic effectors
to prokaryotic and eukaryotic target cells (Ho et al., 2014). The T6SS was first functionally
characterized in Vibrio cholerae and P. aeruginosa PAO1 by the Mekalanos group in 2006
(Mougous et al., 2006; Pukatzki et al., 2006), and thereafter the PAO1 strain has been used as
an important model to study the T6SS functions (Ho et al., 2014; Russell et al., 2014). PAO1
possesses three distinct T6SS clusters (H1, H2, and H3) of which the H1-T6SS delivers six known
antimicrobial substrates (Hood et al., 2010; Whitney et al., 2014). The H2- and the H3-T6SS are
implicated in both antimicrobial and anti-eukaryotic activities and can secrete PldA and PldB
phospholipases, respectively (Lesic et al., 2009; Sana et al., 2012; Russell et al., 2013; Jiang et al.,
2014).
The T6SS main structure consists of an outer sheath, an inner tube, and a membrane-
bound anchor complex (Basler, 2015). Contraction of the outer sheath ejects the inner tube
and its associated effector proteins to the extracellular environment (Ho et al., 2014; Basler,
2015). IcmF, a key T6SS protein, carries an ATPase domain (Ma et al., 2012) and interacts
with TssL and TssJ to form a membrane-spanning complex with a hollow space that allows
the inner tube and effectors to travel through (Basler, 2015; Durand et al., 2015). The recently
published paper by Lin et al. (Lin et al., 2015) reported multiple interesting yet moderate
phenotypes associated with the IcmF3 of the H3-T6SS, including iron acquisition, bacterial
killing, motility, antibiotic resistance, and virulence. However, the molecular mechanism of IcmF3
involvement in such diverse cellular processes is not clear. Because IcmF is required for T6SS
assembly, those reported phenotypes suggest a broad versatile role of the H3-T6SS in PAO1
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(Lin et al., 2015). Interestingly, the T6SS in Yersinia
pseudotuberculosis is involved in Zn2+ transportation (Wang
et al., 2015). An alternative but not mutually exclusive
explanation is that IcmF3 itself regulates other cellular
processes in addition to its primary role as a key T6SS
component.
Lin et al. tested Escherichia coli survival after co-incubation
with PAO1 or the icmF3 mutant for 36 h and reported that
the CFU of E. coli remained at a high level (108 CFU/ml,
see Table S3 in Lin et al., 2015). We found this surprising
because the PAO1 strain in our lab (L-PAO1), obtained from
J. Mekalanos (Mougous et al., 2006; Basler et al., 2013) and
originally from S. Lory, can efficiently kill E. coli cells after 24 h
co-incubation. Considering the reported genome divergence of
PAO1 in different laboratories (Klockgether et al., 2010), we
hypothesized that different PAO1 sublines may have variable
killing abilities against E. coli. To test this hypothesis, we
carried out E. coli killing assays using several PAO1 strains
from different sources (Figure 1A), of which the L-PAO1 has
been used extensively in T6SS research (Mougous et al., 2006;
Hood et al., 2010; Basler et al., 2013; Ho et al., 2013). The H-
PAO1 and the M-PAO1 are isolates from R. Hancock and C.
Manoil, respectively, and are the host strains for two defined
PAO1 transposon mutant libraries (Jacobs et al., 2003; Lewenza
et al., 2005). The P-PAO1 strain and the V-PAO1 strain are
from M. Parsek (Colvin et al., 2011) and E. Banin (Cohen
et al., 2015), respectively. We followed the reported protocol
by Lin et al. (2015) with minor modifications, primarily that
FIGURE 1 | Survival of E. coli MG1655 cells after incubation with different Pseudomonas aeruginosa PAO1 strains. (A) The source of strains used in this
study. (B) Survival of E. coli MG1655 pPSV37 enumerated by serial dilutions. L-PAO11T6SS-1 is the tssB1 mutant defective in the H1-T6SS, and L-PAO11T6SS is
the tssB1-3 triple mutant defective in all three T6SS systems. (C) Summary of the killing assays. Experiments were performed three times. The mean values and the
standard errors are shown.
the killing was done on LB medium directly instead of a filter
membrane. Overnight cultures of PAO1 and E. coli MG1655
carrying a pPSV37 plasmid vector (gentamycin resistance) (Lee
et al., 2010) were washed with fresh LB and then mixed at a
10 to 1 ratio, followed by co-incubation on a LB agar plate
at 37◦C for 36 h. Survival of E. coli was enumerated by serial
dilutions on LB-gentamycin plates. Our results demonstrate that
L-PAO1, V-PAO1, and H-PAO1 eliminated E. coli MG1655
after co-incubation, whereas P-PAO1 and M-PAO1 had little
killing activity against E. coli (Figures 1B,C). To test if the
T6SS is required for the observed killing, we constructed
the tssB1 deletion mutant (1H1-T6SS) and the tssB1-3 triple
deletion mutant (1T6SS) in the L-PAO1 strain. Our results show
that both mutants killed E. coli efficiently, suggesting L-PAO1
possesses other antimicrobial mechanisms independent of the
T6SS clusters.
The genome divergence of different PAO1 strains is known
to cause phenotypic variations in virulence (Preston et al.,
1995; Klockgether et al., 2010). Here we show different PAO1
strains also differ in their capability of killing neighboring
cells. In complex multispecies environments such as the cystic
fibrosis patient’s lung, it is conceivable that competition between
different species may select for PAO1 mutants with enhanced
killing abilities. However, how PAO1 strains during lab passage
diverge to gain/lose antimicrobial properties is not intuitively
apparent. Nonetheless, because PAO1 is widely used as a model
strain, researchers should be aware of the strain variations
and should provide detailed description of the strain source
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to allow the P. aeruginosa community to better interpret the
results.
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